International comparison of generic medicine prices

Current Medical Research and Opinion

Volumn 23, Issue 11, 2007, Pages 2647-2654

  Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Generic medicine; International perspectives; Pharmaceutical company; Prices

Indexed keywords

GENERIC DRUG;

AMBULATORY CARE; ARTICLE; DRUG COST; DRUG MANUFACTURE; DRUG RESEARCH; EUROPEAN UNION;

DRUG COSTS; DRUGS, GENERIC; EUROPE; INDIA; INTERNATIONALITY;

EID: 36348988465     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X233395     Document Type: Article

References (13)

1. Directive 2004/27/EC of the European Parliament and of the Council of 31st March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L 136/34-57
2. European Generic Medicines Association. Basic notions of generics. Brussels: European Generic Medicines Association, 2007. Available at: www.egagenerics.com [Last accessed 26 March 2007]
3. European Commission. Innovation in the pharmaceutical sector. Brussels: Charles River Associates, 2004. Available at: pharmacos.eudra.org [Last accessed 12 March 2007]
4. Karwal V. The changing competitive landscape in the global generics market: threat or opportunity? J Generic Medicines 2006;3:269-79
5. Perry G. The European generic pharmaceutical market in review: 2006 and beyond. J Generic Medicines 2006;4:4-14
6. Simoens S, Decoster S. Sustaining generic medicines markets in Europe. Leuven: Katholieke Universiteit Leuven, 2006. Available at: www.egagenerics.com [Last accessed 8 March 2007]
7. Schulz A. Evolving dynamics of US and European generics markets. J Generic Medicines 2004;2:23-32
8. IMS Health. MIDAS database. Brussels: IMS Health, 2006
9. Patented Medicine Prices Review Board. A study of the prices of the top selling multiple source medicines in Canada. Ottawa: Patented Medicine Prices Review Board, 2002
10. Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin 2007;23: 105-16
11. Patented Medicine Prices Review Board. Non-patented prescription drug prices reporting. Canadian and foreign price trends. Ottawa: Patented Medicine Prices Review Board, 2006
12. Tafuri G, Creese A, Reggi V. National and international differences in the prices of branded and unbranded medicines. J Generic Medicines 2004;1:120-7
13. Danzon P, Chao L. Cross-national price differences for pharmaceuticals: how large, and why? J Health Econ 2000; 19:159-95